ABSTRACT Envisaging 5‐aryltetrahydrobenzazepinone and 5‐aryltetrahydrobenzazepines as conformationally locked potential B 0 AT1 inhibitors, a convenient synthetic route has been developed for their access. The synthetic route banks on using the Schmidt reaction for quick access to symmetrical/unsymmetrical 5‐aryltetrahydrobenzazepinone and 5‐aryltetrahydrobenzazepines.